Australia markets close in 9 minutes

Luyan Pharma Co.,Ltd. (002788.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
7.96+0.10 (+1.27%)
As of 01:48PM CST. Market open.

Luyan Pharma Co.,Ltd.

No. 1004, Anling Road
Huli District
Xiamen 361015
China
86 59 2812 8888
https://www.luyan.com.cn

Sector(s)Healthcare
IndustryPharmaceutical Retailers
Full-time employees5,475

Key executives

NameTitlePayExercisedYear born
Mr. Jinxiang WuChairman & GMN/AN/A1962
Mr. Di WuDeputy GM & Vice ChairmanN/AN/A1991
Ms. Zheng ZengFinancial Director & Accounting SupervisorN/AN/A1986
Mr. Lei MingDeputy GM, Chief Compliance Officer & DirectorN/AN/A1975
Mr. Qizhuan XuAssistant to Chairman & DirectorN/AN/A1962
Mr. Quanqing YeSecretaryN/AN/A1977
Mr. Ming Guo ZhuDeputy General ManagerN/AN/A1969
Mr. Wei Yang LiDeputy General ManagerN/AN/A1970
Ms. Jun Ying ZhangDeputy General ManagerN/AN/A1972
Mr. Jin LiuDeputy General ManagerN/AN/A1975
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. The company was founded in 1992 and is headquartered in Xiamen, China.

Corporate governance

Luyan Pharma Co.,Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.